50,000 patients to reveal how new kidney drug works in real life

NCT ID NCT06278207

Recruiting now Knowledge-focused Sponsor: Bayer Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study will follow 50,000 people in Asia and the United States who have chronic kidney disease and type 2 diabetes and are already taking finerenone as part of their regular care. Researchers will collect data from electronic health records and insurance claims to understand patient characteristics, how the drug is used, and its safety and effectiveness in real-world conditions. No additional visits or tests are required.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Finerenone (Kerendia, Firialta)
What this could lead to: If successful, this study could provide a clearer picture of how finerenone works in everyday medical practice, helping doctors better understand its benefits and risks for people with kidney disease and diabetes.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by differences in patient care or data quality, and no new treatment is being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASE TYPE 2 DIABETES MELLITUS

Contacts and locations

Locations

Bayer
RECRUITING

Berlin, 13353, Germany
Many Locations
COMPLETED

Multiple Locations, New Jersey, 07981, United States
Many Locations
COMPLETED

Multiple Locations, Japan
Many Locations
COMPLETED

Multiple Locations, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.